TransAsia Bio-Medicals donates hematology analyzer to Sri Sathya Sai Institute of Higher Medical Sciences, Bengaluru

Press release for immediate publication

TransAsia Bio-Medicals donates hematology analyzer to Sri Sathya Sai Institute of Higher Medical Sciences, Bengaluru

Bengaluru, March 25, 2019: Transasia Bio-Medicals Ltd., India’s Leading In-vitro Diagnostic Company has donated its newly launched hematology analyzer, H 360 to Sri Sathya Sai Institute of Higher Medical Sciences, Bengaluru. This is in support of the institute’s most urgent need for essential instruments, for more precise diagnosis, faster treatment and improved outcomes. The H 360, is a three part differential fully automated hematology analyzer, developed at Transasia’s European subsidiary - Erba Europe. With its ability to detect CBC and WBC Differential with high precision and accuracy, H 360 will be useful in screening of anemia & its causes, indicating the presence of hemoglobinopathies, helping in detection of cytopenia, septicemia or leukemia and platelet related pathologies & disorders. Transasia has been closely associated with the institute for the last 25 years, supporting the institute with various dedicated initiatives such as blood donation drives, health check-up camps, providing required equipment and contributing to fund-raising activities. Alongwith the H 360, Transasia also announced the launch of two more 5 Part Differential Fully Automated Hematology analyzers, H 560 and Elite 580. Together this entire new range, with a host of features will help institutions, clinicians and laboratory technologists offer accurate diagnosis. The launch of these analyzers has come at an apt time, as Transasia celebrates its 40th anniversary.

In his comments, Suresh Vazirani, Chairman & Managing Director, Transasia Bio-Medicals Ltd. said, “Am immensely proud of Transasia’s continuing association with Sri Sathya Sai Institute of Higher Medical Sciences. The impact of the good work done by the institute has benefited not only the poor patients in Bengaluru but also those from the nearby areas. At Transasia, we believe in operating with a higher purpose, with an unwavering focus on ensuring equitable and affordable access to diagnostic facilities. This latest version of the instrument will be able to offer four more extra parameters for in-depth analysis.”

Added, Dr. Sundaresh D C., Director, Sri Sathya Sai Institute of Higher Medical Sciences, “We are thankful to Mr. Vazirani and Transasia for supporting us with the analyzer. Transasia has a long-standing legacy of offering

quality and affordable diagnostic solutions and I am sure that the additional parameters being offered by this new analyzer will provide more diagnostic value and aid in early and accurate diagnosis.”

About Transasia Bio-Medicals Ltd. :
Founded in 1979, Transasia Bio-Medicals Ltd., India’s Leading In-vitro Diagnostic Company offers products and solutions in Biochemistry, Hematology, Coagulation, ESR, Immunology, Urinalysis, Critical Care, Diabetes Management, Microbiology and Molecular Diagnostics. Transasia provides doctors and patients with reliable, affordable and innovative Medical Diagnostic Systems, with an impressive install base of above 65,000 equipment across India. It has a vast network of the more than 250 service engineers, 400+ sales and marketing team, 23 zonal offices and 350+ distributors. It is the first Indian company to manufacture and export blood analyzers and reagents, in the 1990s. Today, Transasia’s indigenous research has resulted in development of state of the art, ‘Make in India’ products and technologies, enabling its products to be among the best in the world. All along its journey spanning more than four decades, Transasia has been recognized for its commitment to healthcare. It has been conferred ‘India Medical Device - Export Company of the Year’ and the ‘Global Growth Company-2014’ by the World Economic Forum amongst many others. Headquartered in Mumbai, Transasia is a part of the global Transasia-Erba group. The group has spread its footprint across USA, UK, Germany, Czech Republic, France, Italy, Russia and Turkey through various acquisitions. Transasia-Erba Group’s production sites in India, Czech Republic and USA and R&D centres in France, UK, India and Czech Republic form a hub for indigenous manufacturing of world class deliverables. Today, the group serves millions across 100 countries. For further information, kindly visit www.erbamannheim.com
For editorial queries only contact:
Divya, PRHUB I Mobile: +917353270018 I divya@prhub.com / Sanjay, PRHUB I Mobile: +919632387860 I sanjay@prhub.com

Founded in 1979, Transasia Bio-Medicals Ltd., India’s Leading In-vitro Diagnostic Company offers products and solutions in Biochemistry, Hematology, Coagulation, ESR, Immunology, Urinalysis, Critical Care, Diabetes Management, Microbiology and Molecular Diagnostics.

Comapny: PRHUB Integrated Marketing Communication Pvt. Ltd.
Postal Address: #22, Samson Arcade, Ground Floor, Andree Road, Shanthinagar, Bangalore-560027.
Contact Number: 735370018.

This release was published on openPR.